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Visualizing structures deep inside opaque biological tissues is one
of the central challenges in biomedical imaging. Optical imaging
with visible light provides high resolution and sensitivity; how-
ever, scattering and absorption of light by tissue limits the imaging
depth to superficial features. Imaging with shortwave infrared
light (SWIR, 1–2 μm) shares many advantages of visible imaging,
but light scattering in tissue is reduced, providing sufficient optical
penetration depth to noninvasively interrogate subsurface tissue
features. However, the clinical potential of this approach has been
largely unexplored because suitable detectors, until recently, have
been either unavailable or cost prohibitive. Here, taking advantage
of newly available detector technology, we demonstrate the poten-
tial of SWIR light to improve diagnostics through the development of
a medical otoscope for determining middle ear pathologies. We show
that SWIR otoscopy has the potential to provide valuable diagnostic
information complementary to that provided by visible pneumoto-
scopy. We show that in healthy adult human ears, deeper tissue
penetration of SWIR light allows better visualization of middle ear
structures through the tympanic membrane, including the ossicular
chain, promontory, round window niche, and chorda tympani. In ad-
dition, we investigate the potential for detection of middle ear fluid,
which has significant implications for diagnosing otitis media, the
overdiagnosis of which is a primary factor in increased antibiotic re-
sistance. Middle ear fluid shows strong light absorption between
1,400 and 1,550 nm, enabling straightforward fluid detection in a
model using the SWIR otoscope. Moreover, our device is easily trans-
latable to the clinic, as the ergonomics, visual output, and operation
are similar to a conventional otoscope.
shortwave infrared | optical imaging | endogenous contrast | otoscopy |
otitis media
Optical imaging and spectroscopy are well-established methodsof investigating tissues in vivo and have proven valuable for
many diagnostic applications (1–3). A biological tissue sample is
illuminated with light and the structural composition and function
of the sample can be determined from the diffusely reflected or
transmitted light. Equipment for optical measurements is often
simple and portable, interrogations can be carried out without
contacting or perturbing the tissue over a wide field of view, and
the resulting data are generally easy to interpret, all of which
have made optical imaging a powerful technique in clinical set-
tings (1, 4). Most optical imaging thus far uses visible and/or near
infrared (NIR) light between 400 and 1,000 nm, which can be
detected with inexpensive silicon-based sensors. In this wave-
length region, oxygenated and deoxygenated hemoglobin are the
primary physiologically active optical absorbers, and the func-
tional status of tissue can be measured based on their relative
concentrations (5–8).
Extending optical measurements into the shortwave infrared
(SWIR; 1,000–2,000 nm) offers several advantages over visible
and NIR imaging for certain in vivo applications (3, 9–11). The
SWIR regime features absorption from tissue constituents such
as water (near 1,150, 1,450, and 1,900 nm), lipids (near 1,040,
1,200, 1,400, and 1,700 nm), and collagen (near 1,200 and 1,500 nm)
that are more prominent than corresponding features in the visible
and NIR regions (12). The enhanced sensitivity to these chromo-
phores enables better characterization of changes in their concen-
tration, with recent spectroscopy-based examples in detecting and
monitoring cancerous tissues (13–15), burns (3), and intestinal is-
chemia (16), distinguishing skin bruises from surrounding tissue
(17, 18), and discriminating histologically vulnerable and stable
plaques of blood vessels in vivo (19–21). In addition, SWIR light
offers greater transmission through biological tissue than visible
or NIR light due to decreased scattering of photons (9, 22, 23).
SWIR light thus provides sufficient optical penetration depth to
noninvasively interrogate changes in subsurface tissue features,
whereas most visible and NIR imaging is limited to superficial
structures (11, 22).
Despite these advantages, the SWIR regime has thus far been
underused in optical imaging, and in particular, medical devices
have been mostly limited to exploratory or proof-of-principle in
nature. The limited development of SWIR technology is in part
due to the cost-prohibitive nature of nonsilicon semiconductor
detector arrays and restricted access due to national defense-
related policies such as International Traffic in Arms Regula-
tions (ITAR). However, recent technological advances and an
increasing supply of SWIR detectors has enabled a price drop of
roughly an order of magnitude over the time period from 2010 to
2014 (12). Advances in detector fabrication have also produced
high performing sensors with significantly smaller form factors
and reduced weight. Based on such a newly available sensor, we
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show here an application of SWIR light in a medical otoscope
for evaluating transtympanic middle ear pathologies.
Visible light-based pneumotoscopes have been the diagnostic
workhorse for external auditory canal and middle ear examination
for over a century. Using this tool, physicians assess middle ear
pathologies based on the appearance of the tympanic membrane,
or ear drum, and its mobility against hand-generated pneumatic
pressure. The pneumotoscope serves as an initial means of iden-
tifying tympanic membrane perforations, causes of conductive
hearing loss, and most commonly, otitis media, which refers to a
continuum of inflammatory conditions of the middle ear including
acute infection. Otitis media is second in frequency only to acute
upper respiratory infection as the most common illness diagnosed
in US children; at least 80% of children will have experienced one
or more episodes of otitis media by the age of 3 y (24–27).
However, otoscopic examinations are known to have subjective
interpretations, especially in the hands of inexperienced practi-
tioners (28, 29). Successful diagnosis of otitis media is estimated at
51% for US pediatricians, with overdiagnosis of acute otitis media
(false positives) occurring 26% of the time (30–32). The resulting
variation in antibiotic therapy has made otitis media a primary
factor in increased antibiotic resistance (33–35). On the other
hand, failure to diagnose otitis media can lead to long-term hearing
impairment, intracranial complications, a delay in language acqui-
sition, or formation of destructive skin growths, known as choles-
teatoma, which can only be treated by surgical excision (36–39). The
limitations of pneumotoscopy are related in part to the thickness of
the tympanic membrane, which despite being semitranslucent, re-
flects, absorbs, and scatters incident light at the surface, limiting
signal penetration to deeper middle ear structures or fluid. A study
by Rosenfeld of 135 acute otitis media cases diagnosed by US pri-
mary care practitioners found that 40 were false positive, 35 of
which had no middle ear effusion (40).
Here we describe the development of an otoscope sensitive to
SWIR light for more objective diagnoses of transtympanic middle
ear pathologies. A SWIR otoscope maintains the ergonomics, visual
output, and small footprint of a conventional otoscope, making it
easily translatable to the clinic. Meanwhile, SWIR endogenous
contrast provides a unique image that can be applied to the iden-
tification of middle ear abnormalities. Deeper tissue penetration is
achievable with SWIR light than with visible light, allowing better
visualization of middle ear structures through the tympanic mem-
brane. A clearer view of these structures would aid in identifying
causes of conductive hearing loss. In addition, strong SWIR light
absorption of water provides more evident contrast between the
presence and absence of optically dense middle ear effusions, which
could aid in the diagnosis of otitis media. Therefore, a SWIR oto-
scope could complement conventional pneumotoscopic diagnoses
by providing access to the inherent optical properties of the middle
ear across an extended wavelength range.
Results
Light Attenuation of Human Tympanic Membrane Tissue. To predict
the performance of a SWIR otoscope in vivo, we investigated the
optical properties of human tympanic membrane tissue. Spec-
troscopic characterization verifies decreasing light attenuation
with increasing wavelength (Fig. 1A), which is consistent with the
inverse power law relationship between wavelength and scatter-
ing of photons measured previously for skin (22, 23). The en-
hanced transmission of SWIR light is advantageous for an otoscope,
given that light must pass through the tympanic membrane after
reflecting off of the middle ear structures, such as the highly re-
flective ossicles and the promontory, before being detected. Any
absorption or scattering of light by the tympanic membrane in-
evitably decreases the amount of light that can be delivered to the
middle ear structures and further decreases the reflected signal
intensity as it traverses back to the detector. However, more im-
portantly, scattering decreases image contrast and resolution as
reflected light travels indirectly through the tympanic membrane
to the detector (Fig. 1 B and C, SI Results, and Fig. S1).
Absorption beyond 1,300 nm is also evident in the tympanic
membrane attenuation spectrum due to water in the tissue. Al-
though this absorption attenuates overall signal, it does not de-
crease image contrast and resolution. Even considering the
absorption by water, the overall transparency of the tympanic
membrane is greater at SWIR wavelengths than in the visible.
Noninvasive SWIR Imaging of Human Middle Ear Anatomy. To take
advantage of the decreased light scattering of SWIR light, we
designed an SWIR otoscope prototype capable of imaging the
middle ear from 900 to 1,700 nm (Fig. 2). Using a 5.0-mm
speculum, the device images an ∼10.5-mm-diameter circular field
of view with maximum resolution of 45 μm (Fig. S2).
We tested in vivo performance of the SWIR otoscope on ten
adults (18 ears) and show that the increased penetration of SWIR
light through the tympanic membrane enables the SWIR otoscope
to image middle ear anatomy with exceptional detail compared with
visible otoscopy (Fig. 3, Figs. S3 and S4, and Table S1 summarize
the results). In a typical visible examination, the only clearly iden-
tifiable features besides the tympanic membrane are those that are
large or superficial, such as the cochlear promontory (15/18 cases),
which is formed by the outward projection of the first turn of the
cochlea against the posterior wall of the middle ear cavity, and the
malleus (18/18 cases), which lies directly under the tympanic
membrane. In a few cases, the tympanic membrane is thinner,
Fig. 1. Attenuation of human tympanic membrane tissue. As wavelength
increases, light scattering by the tissue decreases, causing attenuation to
decline proportional to the inverse power law λ-0.26 (A, dashed gray line).
Absorption by water in the tissue causes attenuation around 1,440 nm and
absorption by hemoglobin causes small features at 540 and 575 nm. Noise in the
spectrum around 800 nm is due to poor detector sensitivity and grating effi-
ciency in this region under conditions of low light transmission. The spectrum
indicates that light reflected by the middle ear ossicles and promontory would
scatter less through the tympanic membrane for SWIR light (C) compared with
visible light (B), resulting in greater visibility (Fig. S1).
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and light reflection off of smaller or deeper anatomy such as the
incus (9/18 cases), stapes (2/18 cases), and stapedial tendon (2/18)
is identifiable.
The SWIR otoscope, on the other hand, images landmarks of
the entire ossicular chain (middle ear bones) (Movie S1), in-
cluding the incus and stapes (16/18 and 11/18 cases, respectively),
in addition to the malleus (18/18 cases). In 12 of 18 cases, it was
also possible to image the supporting stapedial tendon. Besides
the ossicular chain, the SWIR otoscope can also clearly image
the cochlear promontory (18/18 cases), and visualization of the
round window niche—one of the two openings from the middle
ear to the inner ear—was also achieved (16/18 cases). Further-
more, the SWIR otoscope could identify the chorda tympani
(9/18 cases), a branch of the facial nerve that carries taste sen-
sation from the anterior two-thirds of the tongue. The location of
the chorda tympani is generally obstructed by a thicker region of
the tympanic membrane with visible imaging (visible in 4/18 cases).
Thus, the SWIR otoscope enables visualization of anatomical
features that would normally be undetectable due to poor trans-
mission of visible light through the tympanic membrane. For those
middle ear structures already detectable by visible examination, the
SWIR otoscope further improves the contrast of these features; we
show that the contrast of the incus is enhanced by two times on
average for the round window and four times on average for the
incus (Fig. S5 and SI Results).
Light Attenuation of Middle Ear Fluid. As otitis media is the most
common pathology observed with an otoscope, we investigated
the potential of SWIR light to improve the accuracy of this di-
agnosis. One of the greatest challenges in the diagnosis of otitis
media is the reliable identification of fluid accumulation, or ef-
fusion, behind the tympanic membrane in the middle ear. When
middle ear effusion is accompanied by rapid onset of one or
more signs or symptoms of infection, such as fever, pain and/or
irritability, the patient is diagnosed with acute otitis media and
treatment with antibiotics is indicated. We acquired several hu-
man middle ear fluid samples of a variety of consistencies,
ranging from serous to mucoid, to assess their optical charac-
teristics and determine at which wavelength the greatest optical
contrast can be achieved.
Spectroscopic characterization confirms strong attenuation of
specific spectral bands of SWIR light (Fig. 4). Water in the fluid
gives rise to absorption observed in small features around 970
and 1,180 nm and strong features around 1,440 nm and beyond
1,800 nm, corresponding to the vibrational overtone of the O-H
bond, and the first overtone of O-H stretching, respectively.
Thicker-consistency mucoid middle ear fluid samples contain
less water relative to thin samples, but water absorption is still
the dominant cause of attenuation (Fig. S6). Two peaks are also
distinguishable at 540 and 575 nm from the absorption of oxy-
genated hemoglobin, but middle ear fluid generally appears
translucent by eye due to minimal absorption of chromophores
at visible wavelengths (see Fig. S7 for variation in hemoglobin
Fig. 2. Schematic and image of the SWIR otoscope. The SWIR otoscope
prototype is composed of a compact InGaAs SWIR detector, a filter holder, a
pair of achromatic doublet lenses, a fiber-coupled light source, and a dis-
posable medical speculum (A). The device is 20 × 17 × 5 cm in size and weighs
∼500 g (B).
Fig. 3. Schematic of the middle ear and comparison between SWIR and visible examinations in healthy adults. Representative images from examinations of 10
healthy adult humans are shown. Under visible examination, all anatomy besides themalleus is obstructed by the tympanic membrane (B). Using the SWIR otoscope,
the chorda tympani, malleus, incus, stapes, stapedial tendon, cochlear promontory, and round window niche (indicated by ct, m, i, s, st, p, and rw, respectively, and
shown schematically in A) are all clearly identifiable (C). See Fig. S3 for outlines of the anatomical features and Fig. S4 for additional SWIR images.

























content). Light scattering processes that occur within the viscous
mucous also cause attenuation, particularly at visible wavelengths
of light (400–700 nm). The strength of this wavelength de-
pendence is a complicated function of the geometry of the scat-
tering particles, which vary with the composition of individual fluid
samples; however, in general, the attenuation steadily rises with
decreasing wavelength. In the thickest samples, attenuation is as
strong at visible wavelengths due to scattering, as it is in the SWIR
due to water absorption.
We therefore expect SWIR wavelengths to provide better
optical contrast than visible and NIR imaging in the detection of
middle ear fluid, due to the strong absorption endogenous to
water in the fluid, regardless of fluid consistency.
Detection of Middle Ear Fluid Phantom in a Middle Ear Model. We
evaluated the effectiveness of the SWIR otoscope at detecting fluid
by imaging fluid in a 3D-printed middle ear model (Fig. 5). In our
model, orange juice was selected as a phantom for middle ear fluid,
as it has representative spectroscopic properties, particularly the
dominant water absorption features and scattering of visible wave-
lengths of light (Fig. S8). Using visible otoscopy, slow addition of
fluid into the ear model is barely perceptible (Movie S2); reflected
light intensity from the middle ear space decreases by less than 30%
(Fig. S9A). The malleus, which is a superficial anatomical structure,
experiences relatively less change in intensity as fluid is added. As a
result, the Weber contrast of this feature, defined as the difference
between the feature intensity and the background intensity all di-
vided by the background intensity, is doubled from 0.36 to 0.72
when the malleus is surrounded with fluid (Fig. 5C).
In contrast, using a 1,300-nm long-pass filter and SWIR de-
tection, the SWIR otoscope can selectively image between 1,300
and 1,700 nm where absorption of middle ear fluid is maximal.
Addition of fluid to the model (Movie S3) obstructs any features
lying behind the superficial structures at the tympanic membrane
and reduces the overall reflected light intensity by nearly 75%
(Fig. 5B and Fig. S9B). This notable intensity reduction causes
contrast of the malleus to increase fourfold from 0.30 to 1.2
when surrounded by fluid (Fig. 5D)—a significant improvement
over the visible case (Fig. 5E).
Based on these models and spectroscopic characterization, we
therefore expect the imaging contrast of middle ear fluid in vivo to
be significantly enhanced with SWIR light compared with what is
currently available with visible otoscopy. The relative level of SWIR
absorption, which provides a striking contrast, could facilitate a
clinician’s determination of the absence or presence of fluid in the
middle ear.
Discussion
We developed an otoscope sensitive to SWIR light for middle
ear disease diagnostics. We show that deeper tissue penetration
of SWIR light enhances contrast and enables better visualization
of middle ear anatomy through the thin tissue of the tympanic
membrane. Although the middle ear anatomy is obfuscated by the
tympanic membrane during visible light examinations, SWIR oto-
scopy can be used to examine the ossicular chain, cochlear prom-
ontory, round window niche, and chorda tympani. The ability to
inspect the ossicular chain in greater detail could provide valuable
diagnostic information in cases of conductive hearing loss such as in
ossicular discontinuity or otosclerosis, a disorder characterized by
abnormal bone growth. Imaging deeper within the middle ear can
also allow evaluation of cholesteatoma extension within the middle
Fig. 4. Optical properties of human middle ear fluid. The attenuation of
light through a sample of middle ear fluid shows strong absorption between
1,400 and 1,550 nm due to water content. This absorption of SWIR light
causes the fluid to appear black in a SWIR image, whereas it is translucent
with visible imaging or by eye.
Fig. 5. Contrast between the presence and absence of fluid in a model
middle ear with visible vs. SWIR otoscopy. As the model middle ear is filled
with fluid phantom, a subtle intensity change behind the membrane can be
observed using visible otoscopy (A). The SWIR otoscope provides a more striking
contrast between presence and absence of fluid, particularly with a 1,300-nm
long-pass filter that selectively passes the wavelengths of maximum fluid ab-
sorption (B). Monitoring the Weber contrast of the model structure shows that
the contrast of this feature using SWIR otoscopy increases fourfold to 1.2 (D)
compared with contrast in the absence of fluid of 0.30. This increase is a signif-
icant improvement over the twofold contrast increase from 0.36 to 0.72 observed
using visible otoscopy (C). The Weber contrast for each case is plotted in E.
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ear, especially in cases where the ossicular chain is suspected to be
involved. The round window is used as an insertion site for cochlear
implant electrodes and has also recently been used as an implan-
tation site for hearing aid transducers (41–43). Clear visualization of
the round window using a SWIR otoscope could provide an al-
ternative to radiographic imaging for evaluation of such surgical
implants. Thus, a SWIR otoscope has diagnostic potential in
evaluating the cause of a variety of middle ear complications and
in informing surgical procedures.
Furthermore, we predict that a SWIR otoscope can indicate
middle ear effusions based on the strong light absorption of middle
ear fluid beyond 1,300 nm. Otoscopy is the most widely used tech-
nology for assessing middle ear effusions; however, studies have
shown that current visible light-based otoscopy is limited in accuracy,
with correct interpretation by 46% of general practitioners, 51% of
pediatricians, and 76% of otolaryngologists (28, 32, 44). Integrating
SWIR light into otoscopy extends the available wavelengths to a
regime in which endogenous contrast of middle ear fluid is much
greater than at visible wavelengths. It should therefore provide a
more objective determination of the presence or absence of middle
ear effusion. Bringing objectivity to this diagnosis, which has long
been plagued by diagnostic and therapeutic inconsistency, has the
potential to reduce overprescription of antibiotics and unnecessary
tympanostomy tube surgeries, which is the most common surgical
procedure performed in US children (45). Potentially, an SWIR
otoscope could also be used for differential detection of mucoid
versus serous middle ear effusion, which is also of clinical interest.
Measuring the attenuation of the middle ear at different wavelength
regimes (e.g., 1,100 vs. 1,450 nm) simultaneously should enable
distinction of thin vs. thick ear fluid with high accuracy, possibly
giving a measure of the volumetric percentage of water in the fluid.
We underscore the importance of having a photonic method for
direct visualization of the functional status of biological tissue.
Tympanometry is an audiometric method shown to raise diagnostic
success of otitis media to 83%; however, this method is not widely
used in primary care settings, largely because nonspecialists lack
training in this technique and are inhibited by the cost (28, 35, 46).
Emerging technologies such as optical coherence tomography,
spectral gradient acoustic reflectometry, and sonography have
likewise shown potential for improving the diagnosis of otitis me-
dia, but thus far have not been widely adopted in general practice
due to the difficulty of data interpretation or unfamiliarity of
physicians with their use. (47–50) Using SWIR technology does
not add time or complexity to a diagnosis and requires little ad-
ditional training of medical practitioners who have already been
trained in otoscopy. It is thus easily integrated into the clinic.
The general architecture of the SWIR otoscope, which provides
immediate functional information, could be extended to the devel-
opment of a variety of other medical devices to assist in a wide range
of surgical procedures throughout the airway and gastrointestinal
tract. Other disease conditions characterized by the buildup of fluid
could be characterized by the enhanced contrast due to endogenous
SWIR absorption. The SWIR otoscope is therefore only an initial
example of how extending optical measurements into the SWIR can
provide complimentary visual data and address existing limitations
of conventional visible light-based medical devices.
Methods
Spectroscopy of Human Tympanic Membrane Tissue and Middle Ear Fluid.
Human tympanic membrane tissue samples (∼1-mm sections) were col-
lected intraoperatively from pediatric patients (ages 0–18 y) during a typical
tympanoplasty procedure. Human middle ear fluid samples (30- to 200-μL
volumes) were collected intraoperatively from pediatric patients during
myringotomy and placement of pressure-equalizing tubes for standard
treatment of recurrent otitis media or persistent middle ear effusion. SI
Methods provides information on sample collection, storage, and prepara-
tion details. Attenuation was measured using a Cary 5000 UV-VIS-NIR spec-
trophotometer (Varian/Agilent). All biospecimen sample collection and
transfer procedures were approved by the Connecticut Children’s Medical
Center Institutional Review Board and were from volunteers who provided
informed consent. Samples were used and characterized following the
procedures approved by the Massachusetts Institute of Technology Com-
mittee on the Assessment of Biohazards and Embryonic Stem Cell Research
Oversight and Biosafety Program.
SWIR Otoscope Design. The SWIR otoscope is composed of a fiber-coupled
broadband halogen light source, a medical speculum that guides the device
into the ear canal (Welch Allyn), speculums sized 2.5, 3.0, 4.0, or 5.0 mm), and
a lens system to focus the diffusely reflected light onto an Indium Gallium
Arsenide array detector. The lenses used in these experiments were from an
Edmund Optics NIR achromatic lens pair with 75- and 100-mm effective focal
length achromatic doublet lenses. The detector is a Xenics XS Trigger Indium
Gallium Arsenide detector with a 320 × 256 array of 30-μm pixels and 14-
bit analog-to-digital conversion resolution. A filter holder in front of the
sensor allows easy adaptation with various short-pass, long-pass, and
band-pass filters, enabling optimization of the device sensitivity for a
variety of applications.
Human Middle Ear Imaging. The external auditory canal was used as the
optical access for SWIR imaging of middle ear structures in both the left and
right ears of healthy adults. The speculum was inserted into the canal within
∼2 cm of the tympanic membrane and the middle ear was illuminated with
the light source. Reflected light was collected by the optical system either
broadband or filtered through a band-pass, long-pass, or short-pass filter.
Visible images of the middle ear were taken of each subject in a similar
manner (SI Methods). All participants provided informed consent and con-
sent to publish images, and methods were carried out in accordance with
the procedures approved by the Massachusetts Institute of Technology In-
stitutional Review Board and Committee on the Use of Humans as Experi-
mental Subjects, and Connecticut Children’s Medical Center Institutional
Review Board, and all procedures were in accordance with the Declaration
of Helsinki guidelines.
Middle Ear Phantom. A middle ear phantom was 3D-printed using computer-
assisted design software Solid Edge ST7 (Siemens). The shapes and angles
were modeled to resemble the normal middle ear anatomical configuration
based on previously described anatomical measurements (51). These models
were used as the design files for the 3D printing process. A Makerbot Rep-
licator Desktop 3D Printer (Makerbot Industries) was used with polylactic
acid (PLA) as the printing filament. To model the semirigid and angled na-
ture of the external auditory canal, a 3D-printed PLA cast was made, and
high-performance platinum silicone (Dragon Skin FX-Pro; Smooth On) was
used for the canal castings. The silicone was also cast into a thin, translucent
sheet ∼0.5 mm thick for the tympanic membrane and to line the inside of
the 3D-printed PLA middle ear cavity, representing the mucosa of the
cavity. A small hole in the back of the middle ear cavity was used to add
fluid via a syringe into the phantom behind the silicone tympanic mem-
brane while recording video using the SWIR or a visible otoscope inserted
in the model canal.
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